Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...

Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease ...

Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high ...

UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

The harmful clumps of tau protein that build up in brains affected by Alzheimer's were reduced significantly, and the mice ...

There is progress to report in the battle against Alzheimer's. While there is still no cure, new tests and new treatments are ...

While the drugs cannot cure or reverse the symptoms, they can slow the progression of the disease. Read more at ...

A new Alzheimer’s drug has been hailed as a major breakthrough after clinical trials showed it could clear the harmful brain ...

My husband has Alzheimer's, and my experience as his caregiver influenced me to make 'Walk With Me,' a documentary that ...